Lactase Enzyme Market Is Expected To Reach A Value Of US$ 1.1 Billion By 2033

The global market for lactase enzymes is set to experience consistent growth, with a projected Compound Annual Growth Rate (CAGR) of 4% from 2023 to 2033. Worldwide sales of lactase enzymes are anticipated to increase from US$ 742 million in 2023 to US$ 1.1 billion by 2033.

The rise in lactose intolerance cases in recent years is boosting the consumption of lactase enzymes. This trend is driving the demand for lactase enzyme supplements, such as capsules, tablets, and lactose intolerance pills.

Download Sample Copy Of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=666

Various factors will contribute to the growing demand for lactase enzymes over the next decade. These include evolving consumer food preferences, increased nutritional awareness, a growing elderly population, and a desire for easily digestible foods.

Moreover, the demand for lactose-free products is on the rise.

The shift towards vegan, plant-based, and cruelty-free products is expected to create lucrative opportunities for both established companies and newcomers in the global market.

In the Asia Pacific region, the consumption of lactase enzymes is expected to experience significant growth throughout the forecast period. This growth can be attributed to the increasing availability of lactose-free products, rising awareness of lactose intolerance, a focus on health, and a growing aging population.

Key Companies Profiled
• Symrise AG
• DSM Chemicals
• Chr. Hansen Holding A/S
• Biolaxi Corp.
• Novact Corp.
• Advanced Enzyme Technologies Limited
• DuPont de Nemours and Company
• Merck KGaA (Sigma-Aldrich)
• Natural Factors Nutritional Products Ltd.
• Mitushi Biopharma
• Novozymes A/S
• Sternenzyme
• Infinita Biotech Pvt. Ltd.
• Calza Clemente
• Senson
• Nature BioScience Pvt. Ltd.
• Aumgene Biosciences

Emerging lactase enzyme manufacturers should prioritize advancing product innovation

As newcomers enter the lactase enzyme manufacturing arena, their focus should revolve around expanding the utility of lactase enzymes across diverse product lines. This entails crafting unique offerings that stand out amidst global competition.

• For instance, Painterland Sisters, an up-and-coming organic yogurt provider, showcases innovation by incorporating organic lactase enzymes into their products, catering to individuals with lactose sensitivities. Their skyr yogurt, inspired by Icelandic tradition, not only eliminates lactose but also boasts high protein and probiotic content.
• Similarly, Kiwi Biosciences made waves with the introduction of FODZYME, a cutting-edge enzyme supplement blending lactase enzymes with fructan hydrolase and galacto-oligosaccharides. This patent-pending formula addresses the digestion challenges posed by FODMAPs, catering to a niche yet significant market segment.

Future market entrants are poised to tap into the burgeoning demand for lactose-free alternatives, particularly from the expanding vegan demographic. Moreover, leveraging increasing awareness of lactose intolerance and governmental support for dietary improvements presents a strategic opportunity for new players to carve out their niche in the industry.

Emerging Trends in Lactose Intolerance Spark New Opportunities

Lactose intolerance rates in the United States have been on the rise, poised to significantly impact the demand for lactase enzyme. This surge is influenced by shifting dietary patterns, a burgeoning vegan demographic, increased demand for plant-derived alternatives, and the escalating prevalence of obesity.

According to data from ProCon.org, approximately 36% of the U.S. population is currently affected by lactose intolerance, with projections from a Fact.MR study suggesting a further increase by 2033.

Lactase supplements, including pills and enzyme formulations, are poised for considerable sales growth in the foreseeable future. In 2022, the U.S. dominated North America's lactase enzyme market, capturing an impressive 89% share, with a projected compound annual growth rate (CAGR) of 3.5% over the next decade.

Competitive Landscape
Lactase enzyme companies are investing in the expansion of their research and development scope to increase the scope of application as many manufacturers are incorporating lactase enzymes in their product portfolio.

• In June 2022, Provilac, a milk delivery firm in India announced the launch of its lactose-free cow milk offering. The company aims to expand its offerings and increase its market share in India by 10 to 20 percent over the coming years.
• In August 2021, Good Culture, a cultured foods brand based in the United States announced the launch of its new line of lactose-free products. The product range includes lactose-free cottage cheese and lactose-free sour cream containing lactase enzymes.
• In March 2020, Novozymes, a leading name in the global lactase enzyme industry landscape announced the launch of Saphera Fiber. The newly launched product was a lactase enzyme capable of reducing sugar content in dairy products while increasing fiber.

Key Segments Covered in Lactase Enzyme Industry Research
• By Product Type:
o Fungal Lactase Enzymes
o Neutral Lactase Enzymes

• By Form:
o Dry
o Liquid

• By End Use:
o Food & Beverages
o Dietary Supplements
o Pharmaceuticals

• By Region:
o North America
o Latin America
o Europe
o APAC
o MEA

Read More: https://www.factmr.com/report/666/lactase-enzyme-market

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

About Fact.MR
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.